About David Doyle
Form D filings for Artin Bioscience in 2023 list David Doyle as executive officer and director.
David Doyle first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name David Doyle in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Doyle works with at each company, as listed on that company's latest Form D.
Artin Bioscience Inc. · Form D, Mar 13, 2023
EE
Erik Eglite
Executive officer and director
CM
Charles Magolske
Chief Executive Officer and director
NV
Norbert Voelkel
Director